Winkler G - Search Results

1

The role of tumour necrosis factor (TNF)-alpha resistance in obesity and insulin resistance.

Cseh K, Winkler G, Melczer Z, Baranyi E. Cseh K, et al. Among authors: winkler g. Diabetologia. 2000 Apr;43(4):525. doi: 10.1007/s001250051339. Diabetologia. 2000. PMID: 10819249 No abstract available.

2

Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus.

Winkler G, Dworak O, Salamon F, Salamon D, Speer G, Cseh K. Winkler G, et al. Diabetologia. 1998 Apr;41(4):488. doi: 10.1007/s001250050935. Diabetologia. 1998. PMID: 9562356 No abstract available.

3

[Tumor necrosis factor-alpha; a possible pathogenic factor in obesity in insulin resistant and non-insulin-dependent diabetes mellitus?].

Winkler G, Salamon F, Simon K, Cseh K. Winkler G, et al. Orv Hetil. 1998 Jul 5;139(27):1627-32. Orv Hetil. 1998. PMID: 9685802 Review. Hungarian.

4

Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity.

Winkler G, Salamon F, Salamon D, Speer G, Simon K, Cseh K. Winkler G, et al. Diabetologia. 1998 Jul;41(7):860-1. doi: 10.1007/s001250051000. Diabetologia. 1998. PMID: 9686931 No abstract available.

5

Elevated serum tumor necrosis factor-alpha and endothelin 1 levels correlate with increased C-peptide concentration in android type obesity.

Winkler G, Lakatos P, Nagy Z, Speer G, Salamon F, Szekeres O, Kovács M, Cseh K. Winkler G, et al. Diabetes Care. 1998 Oct;21(10):1778-9. Diabetes Care. 1998. PMID: 9773752 No abstract available.

6

Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity.

Winkler G, Salamon F, Harmos G, Salamon D, Speer G, Szekeres O, Hajós P, Kovács M, Simon K, Cseh K. Winkler G, et al. Diabetes Res Clin Pract. 1998 Dec;42(3):169-74. doi: 10.1016/s0168-8227(98)00109-0. Diabetes Res Clin Pract. 1998. PMID: 9925347

7

Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients.

Winkler G, Lakatos P, Salamon F, Nagy Z, Speer G, Kovács M, Harmos G, Dworak O, Cseh K. Winkler G, et al. Diabet Med. 1999 Mar;16(3):207-11. doi: 10.1046/j.1464-5491.1999.00052.x. Diabet Med. 1999. PMID: 10227565

8

The role of cytokines of the innate and adaptive immune system in the regulation of insulin resistance.

Cseh K, Baranyi E, Winkler G. Cseh K, et al. Among authors: winkler g. Diabetologia. 1999 Apr;42(4):497-8. doi: 10.1007/s001250051187. Diabetologia. 1999. PMID: 10230657 No abstract available.

9

Vitamin D receptor gene BsmI polymorphism correlates with erbB-2/HER-2 expression in human rectal cancer.

Speer G, Dworak O, Cseh K, Bori Z, Salamon D, Török I, Winkler G, Vargha P, Nagy Z, Takács I, Kucsera M, Lakatos P. Speer G, et al. Among authors: winkler g. Oncology. 2000 Apr;58(3):242-7. doi: 10.1159/000012107. Oncology. 2000. PMID: 10765127

10

Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity.

Speer G, Cseh K, Winkler G, Vargha P, Braun E, Takács I, Lakatos P. Speer G, et al. Among authors: winkler g. Eur J Endocrinol. 2001 Apr;144(4):385-9. doi: 10.1530/eje.0.1440385. Eur J Endocrinol. 2001. PMID: 11275948 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters